Citadel Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.4M | Sell |
|
|||||
|
2025
Q1 | $113M | Buy |
|
|||||
|
2024
Q4 | $25.5M | Sell |
|
|||||
|
2024
Q3 | $84.7M | Buy |
|
|||||
|
2024
Q2 | $45.9M | Sell |
|
|||||
|
2024
Q1 | $173M | Buy |
|
|||||
|
2023
Q4 | $34.2M | Buy |
|
|||||
|
2023
Q3 | $12.5M | Sell |
|
|||||
|
2023
Q2 | $41.8M | Buy |
|
|||||
|
2023
Q1 | $12M | Sell |
|
|||||
|
2022
Q4 | $13.5M | Sell |
|
|||||
|
2022
Q3 | $85M | Sell |
|
|||||
|
2022
Q2 | $95.6M | Sell |
|
|||||
|
2022
Q1 | $161M | Buy |
|
|||||
|
2021
Q4 | $120M | Buy |
|
|||||
|
2021
Q3 | $3.79M | Sell |
|
|||||
|
2021
Q2 | $80.1M | Sell |
|
|||||
|
2021
Q1 | $123M | Sell |
|
|||||
|
2020
Q4 | $263M | Buy |
|
|||||
|
2020
Q3 | $188M | Buy |
|
|||||
|
2020
Q2 | $31.4M | Sell |
|
|||||
|
2020
Q1 | $21.9M | Sell |
|
|||||
|
2019
Q4 | $172M | Buy |
|
|||||
|
2019
Q3 | $118M | Buy |
|
|||||
|
2019
Q2 | $100M | Buy |
|
|||||
|
2019
Q1 | $100M | Sell |
|
|||||
|
2018
Q4 | $116M | Sell |
|
|||||
|
2018
Q3 | $238M | Buy |
|
|||||
|
2018
Q2 | $173M | Buy |
|
|||||
|
2018
Q1 | $112M | Sell |
|
|||||
|
2017
Q4 | $206M | Buy |
|
|||||
|
2017
Q3 | $153M | Buy |
|
|||||
|
2017
Q2 | $22M | Sell |
|
|||||
|
2017
Q1 | $41M | Sell |
|
|||||
|
2016
Q4 | $58M | Sell |
|
|||||
|
2016
Q3 | $90M | Sell |
|
|||||
|
2016
Q2 | $129M | Sell |
|
|||||
|
2016
Q1 | $181M | Buy |
|
|||||
|
2015
Q4 | $7.69M | Sell |
|
|||||
|
2015
Q3 | $44.9M | Sell |
|
|||||
|
2015
Q2 | $79.3M | Sell |
|
|||||
|
2015
Q1 | $120M | Sell |
|
|||||
|
2014
Q4 | $132M | Buy |
|
|||||
|
2014
Q3 | $86.7M | Buy |
|
|||||
|
2014
Q2 | $35.3M | Sell |
|
|||||
|
2014
Q1 | $43.5M | Buy |
|
|||||
|
2013
Q4 | $38.5M | Buy |
|
|||||
|
2013
Q3 | $33.7M | Sell |
|
|||||
|
2013
Q2 | $49.5M | Buy |
|